Endothelial Cell Dysfunction and Nonalcoholic Fatty Liver Disease (NAFLD): A Concise Review

Nonalcoholic fatty liver disease (NAFLD) is one of the most common liver diseases worldwide. It is strongly associated with obesity, type 2 diabetes (T2DM), and other metabolic syndrome features. Reflecting the underlying pathogenesis and the cardiometabolic disorders associated with NAFLD, the term metabolic (dysfunction)-associated fatty liver disease (MAFLD) has recently been proposed. Indeed, over the past few years, growing evidence supports a strong correlation between NAFLD and increased cardiovascular disease (CVD) risk, independent of the presence of diabetes, hypertension, and obesity. This implies that NAFLD may also be directly involved in the pathogenesis of CVD. Notably, liver sinusoidal endothelial cell (LSEC) dysfunction appears to be implicated in the progression of NAFLD via numerous mechanisms, including the regulation of the inflammatory process, hepatic stellate activation, augmented vascular resistance, and the distortion of microcirculation, resulting in the progression of NAFLD. Vice versa, the liver secretes inflammatory molecules that are considered pro-atherogenic and may contribute to vascular endothelial dysfunction, resulting in atherosclerosis and CVD. In this review, we provide current evidence supporting the role of endothelial cell dysfunction in the pathogenesis of NAFLD and NAFLD-associated atherosclerosis. Endothelial cells could thus represent a golden target for the development of new treatment strategies for NAFLD and its comorbid CVD.

Automated summary

Nonalcoholic fatty liver disease (NAFLD) is a common liver disease worldwide, strongly associated with obesity, type 2 diabetes, and other metabolic syndrome features. The term metabolic (dysfunction)-associated fatty liver disease (MAFLD) has recently been proposed. Growing evidence supports the strong correlation between NAFLD and increased cardiovascular disease risk, independent of the presence of diabetes, hypertension, and obesity. Liver sinusoidal endothelial cell dysfunction appears to be implicated in the progression of NAFLD and may contribute to atherosclerosis and cardiovascular disease.